Pantoprazole Itopride Pellets Manufacturer & Supplier
Combination pellets uniting proton pump inhibition with prokinetic support for reflux and gastric motility programs.
Product overview
Pantoprazole provides acid suppression while Itopride contributes prokinetic action. The pellet system is structured for homogeneous filling and reliable downstream processing in capsules and multiparticulate dosage forms.
Key characteristics
- Dual-action combination platform.
- Controlled pellet density and particle-size distribution.
- Suitable for capsule and multiparticulate development.
- Support for stability, excipient compatibility, and scale-up.
Product specifications
- Product
- Pantoprazole Itopride Pellets
- Form
- Pellets
- Therapeutic category
- Anti-Ulcerant (PPIs)
- Strength
- 20 mg + 50 mg
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Pantoprazole Itopride Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Pantoprazole products from Rraynex
- Pantoprazole (API) — API
- Clopidogrel + Pantoprazole — Granules
- Metformin + Pantoprazole — Granules
- Pantoprazole + Domperidone — Granules
- Pantoprazole DC — Granules
- 2-(Chloromethyl)-3,4-dimethoxypyridine HCl — Intermediate
- 5-(Difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1H-benzimidazole — Intermediate
- 5-Difluoromethoxy-2-mercaptobenzimidazole — Intermediate
- Pantoprazole — Pellets
- Pantoprazole + Domperidone — Pellets
- Pantoprazole + Levosulpiride — Pellets
- Pantoprazole MUPS — Pellets